These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6505142)

  • 21. Hypoxia-selective nitrobenzyloxycarbonyl derivatives of 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazines.
    Shyam K; Penketh PG; Shapiro M; Belcourt MF; Loomis RH; Rockwell S; Sartorelli AC
    J Med Chem; 1999 Mar; 42(5):941-6. PubMed ID: 10072691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of BMS-181174 and radiation: studies with EMT6 cells in vitro and in solid tumors.
    Rockwell S; Kelley M
    Radiother Oncol; 1996 Apr; 39(1):65-71. PubMed ID: 8735495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU.
    Twentyman PR
    Cancer Clin Trials; 1980; 3(3):253-6. PubMed ID: 7438322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain.
    Wiedenmann N; Valdecanas D; Hunter N; Hyde S; Buchholz TA; Milas L; Mason KA
    Clin Cancer Res; 2007 Mar; 13(6):1868-74. PubMed ID: 17363543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy.
    Korbelik M; Krosl G; Krosl J; Dougherty GJ
    Cancer Res; 1996 Dec; 56(24):5647-52. PubMed ID: 8971170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
    Chan WS; Brasseur N; La Madeleine C; van Lier JE
    Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined use of radiosensitizing and protective agents in experimental radiotherapy].
    Magdon E; Schröder E; Iarmonenko SP; Vygodskaia AL; Vinskaia NP
    Med Radiol (Mosk); 1984 Dec; 29(12):29-32. PubMed ID: 6513748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of pH on the cytotoxicity of cisplatin in EMT6 mouse mammary tumor cells.
    Laurencot CM; Kennedy KA
    Oncol Res; 1995; 7(7-8):371-9. PubMed ID: 8747600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular radiosensitivity and tumor radiation response in the EMT6 tumor cell system.
    Rockwell S; Kallman RF
    Radiat Res; 1973 Feb; 53(2):281-94. PubMed ID: 4695229
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination therapy with radiation, mitomycin C, and 5-fluorouracil in EMT6 tumors.
    Rockwell S
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):127-33. PubMed ID: 8270433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy with misonidazole and mitomycin C: lack of chemosensitization of EMT6 tumor cells in vivo or in vitro.
    Rockwell S
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1631-4. PubMed ID: 6434497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
    Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
    Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of 2-amino-5-nitrothiazole as a hypoxic cell radiosensitizer.
    Rockwell S; Mroczkowski Z; Rupp WD
    Radiat Res; 1982 Jun; 90(3):575-85. PubMed ID: 7045963
    [No Abstract]   [Full Text] [Related]  

  • 35. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
    Teicher BA; Holden SA; Ara G; Dupuis NP; Goff D
    Cancer J Sci Am; 1995; 1(1):43-8. PubMed ID: 9166453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582.
    Denekamp J; Harris SR
    Radiat Res; 1976 Apr; 66(1):66-75. PubMed ID: 1257411
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of nitrobenzimidazoles as hypoxic cell radiosensitizers.
    Wright J; Frank LR; Bush D; Harrison GH
    Radiat Res; 1983 Jul; 95(1):187-96. PubMed ID: 6348867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell survival in V79 multicell spheroids treated with dehydroascorbate, 5-thio-D-glucose and 2-deoxy-D-glucose.
    Sridhar R; Koch CJ; Stroude EC; Inch WR
    Br J Cancer Suppl; 1978 Jun; 3():141-4. PubMed ID: 277214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adducts of mitomycin C and DNA in EMT6 mouse mammary tumor cells: effects of hypoxia and dicumarol on adduct patterns.
    Bizanek R; Chowdary D; Arai H; Kasai M; Hughes CS; Sartorelli AC; Rockwell S; Tomasz M
    Cancer Res; 1993 Nov; 53(21):5127-34. PubMed ID: 7693331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin.
    Cheung RY; Rauth AM; Ronaldson PT; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2006 Apr; 62(3):321-31. PubMed ID: 16330194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.